GLOBAL NEWS
REUTERS
THE NEW YORK TIMES
YAHOO
US BUSINESS
CNBC
EQUITIES
THE WALL STREET JOURNAL
US MARKET
CNBC
MARKETWATCH
NASDAQ
YAHOO
US MARKET BLOGS
CNBC
REDDIT
ZERO HEDGE
US MUTUAL FUNDS BLOGS
INVESTORS BUSINESS DAILY
REDDIT
US NEWS
CNBC
MARKETWATCH
THE NEW YORK TIMES
YAHOO
 Save

US MARKET | Sat, 1 Aug 2026, 4:15PM ET Key PointsAll three of these companies have exceptional dividend track records.

Continue reading at Nasdaq

32m

US MARKET | Sat, 1 Aug 2026, 3:59PM ET Key PointsSilicon Motion more than doubled its revenue year over year while implying up to 20% sequential growth in Q3.

Continue reading at Nasdaq

48m

US MARKET | Sat, 1 Aug 2026, 3:55PM ET Key PointsAlphabet has incentives to develop a strong quantum computing unit for its cloud computing services.

Continue reading at Nasdaq

52m

US MARKET | Sat, 1 Aug 2026, 3:35PM ET Key PointsNextEra Energy is leaning into the growing demand for electricity by buying peer Dominion Energy.

Continue reading at Nasdaq

1h

US MARKET | Sat, 1 Aug 2026, 3:29PM ET Key PointsCitigroup reduced its price target on EPAM Systems stock.

Continue reading at Nasdaq

1h

US MARKET | Sat, 1 Aug 2026, 3:03PM ET Key PointsBitcoin has historically followed a four-year cycle of boom and bust, with three good years followed by one bad year.

Continue reading at Nasdaq

1h

US MARKET | Sat, 1 Aug 2026, 2:48PM ET Key PointsVanguard Russell 1000 Growth ETF provides concentrated exposure to large-cap technology leaders while Vanguard Morningstar Small-Cap Growth ETF focuses on smaller companies

Continue reading at Nasdaq

1h

US MARKET | Sat, 1 Aug 2026, 2:35PM ET Key PointsAmong the states that do tax Social Security, most do so with a light touch.

Continue reading at Nasdaq

2h

US MARKET | Sat, 1 Aug 2026, 2:31PM ET Key PointsBloom Energy reported stellar results for the second quarter of 2026, surpassing $1 billion in quarterly revenue for the first time.

Continue reading at Nasdaq

2h

US MARKET | Sat, 1 Aug 2026, 2:17PM ET Key PointsState Street Health Care Select Sector SPDR ETF offers a significantly lower expense ratio of 0.08% compared to 0.58% for Invesco Biotechnology & Genome ETF

Continue reading at Nasdaq

2h
more